When Searching for Economic Catalysts for Small Business, Don’t Overlook Life Science Companies (ROI-NJ.Com)
An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer April 1, 2021 ― Biopharmaceutical and medical technology companies are true pillars of New Jersey’s economy and communities. With an overall economic impact of more than $83 billion (13% of New Jersey’s GDP) and more than 430,000 total life sciences-supported jobs in the […]
Innovation Flourishes Here in New Jersey (NJ.COM)
An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer and Anthony S. Cicatiello, President of the R&D Council of New Jersey March 22, 2021 ― As innovation has sprouted elsewhere, some have reportedly concluded perhaps New Jersey — the cradle of so many technological accomplishments – has lost its leadership edge, particularly […]
Lowering Costs Without Killing Cures (Asbury Park Press)
An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer February 19, 2021 ― Medical innovation in the U.S. is at an inflection point. The breathtaking achievements of our life sciences community in tacking the COVID-19 pandemic further the industry’s legacy of its capacity to respond quickly to health crises.
Patients Must Be Able to Access the Life-saving Medicines NJ Companies Are Producing (NJ.com)
An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer January 9, 2021 ― New Jersey has long been a national and global leader in the advancement of human health. With the most scientists and engineers per square mile in the U.S. and one of the greatest concentrations of life sciences companies on […]
HINJ Statement on COVID Vaccine Rollout
HINJ salutes the work of the life sciences industry during this unprecedented pandemic. “Today’s rollout in New Jersey of the Pfizer and BioNTech vaccine for COVID-19 to health care workers is a major step forward in the effort to combat this pandemic,” said Dean J. Paranicas, president and chief executive officer of HINJ. “And with […]
HINJ Issues Statement on Most Favored Nation Executive Order
The HealthCare Institute of New Jersey (HINJ) supports responsible ways to lower health care costs for patients that do not jeopardize the ability of life sciences companies to research and discover the next generation of treatments and cures for patients everywhere. We remain committed to working with all stakeholders to ensure that new barriers to […]
HINJ Honors Rutgers University and Infinity BiologiX with Research and Innovation Award
HINJ presented Rutgers University and Infinity BiologiX (IBX) with its HINJ Excellence in Research and Innovation Award for their breakthrough research in developing the “saliva test” to identify COVID-19 (SARS-CoV-2). The award was bestowed during the Research and Development Council of New Jersey’s 41st annual Edison Patent Awards event on November 12. “HINJ recognizes Rutgers […]
HINJ Honors NJ Council of County Vocational-Technical Schools with STEM Education Award
HINJ recognized the New Jersey Council of County Vocational-Technical Schools with its HINJ Excellence in STEM Education Award at the Council’s September board meeting. HINJ honored the Council and its members for their leadership in STEM education, bolstering New Jersey’s innovation ecosystem, and guiding students on their career path. HINJ President and Chief Executive Officer […]
HINJ Honors Assemblyman Benson with Bob Franks Award
HINJ Honors Assemblyman Benson with Bob Franks Award HINJ recognized Assemblyman Dan Benson (D-14) with the Bob Franks Public Service Award for demonstrating the spirit of public service that Franks exemplified while in public office and as President and Chief Executive Officer of HINJ. HINJ President and Chief Executive Officer Dean J. Paranicas congratulated the […]
Health Care Technology and the Pandemic
September 1, 2020 – HINJ President and CEO Dean Paranicas served as the moderator for the August 31, 2020 NJBIZ healthcare technology forum. Please read the article about the forum here.